| VVOS 0.1859 -17.34% | CLGN 0.4885 36.45% | AIM 0.2238 -13.39% | RDHL 1.0422 57.67% | PCG 13.505 -18.64% | TSLL 9.86 9.80% | COOT 0.593 28.91% | SOAR 0.245 12.96% | NVD 3.9699 -1.98% | FNGR 0.2344 -41.11% | NVDA 219.83 1.05% | BITO 10.595 1.39% | LGCL 0.0342 -12.08% | NCRA 2.95 56.08% | WBUY 1.03 24.10% | GPRO 0.7199 20.00% | INTC 89.52 0.06% | NU 14.5 1.40% | AEHL 6.99 97.46% | LGPS 1.27 19.81% | TSLA 365.71 4.86% | WETO 10.22 78.67% | AAL 13.425 -1.58% | YDDL 2.1606 30.95% | SPCX 143.21001 1.21% | IBIT 44.5078 1.38% | TQQQ 71.097 -1.05% | SOXS 49.88 0.12% | NOK 10.07 -1.37% | SQQQ 38.945 1.05% | PATH 18.655 2.78% | ABEV 2.88 0.70% | SPDN 8.545 0.65% | NCPL 0.7143 3.28% | SNAP 5.515 1.57% | SOXL 111.125 -0.19% | RZLV 2.89 -2.69% | IREN 36.145 1.96% | SOFI 17.855 -1.14% | SGOV 100.695 0.00% | XLU 42.26 -1.10% | RITR 0.0915 4.33% | BMNR 24.38 2.44% | BTG 5.48 -3.18% | F 13.975 0.68% | ETHA 18.595 1.22% | PURR 11.685 0.65% | NIO 4.335 -0.80% | ONDS 7.6899 -2.66% | AUR 5.52 -5.32%

Silvergate Capital Corporation's Public Debut

Silvergate Capital Corporation, trading under the symbol SI on the NYSE, is making its public debut by offering 5 million shares at $15 each. This move marks a significant milestone for the company as it seeks to attract investors and expand its market presence. Silvergate Capital is known for its focus on providing financial infrastructure solutions and services to the digital currency industry.

Currently, SI's stock is priced at $14.25, reflecting a decrease of 5.32% or $0.80. The stock has shown volatility, with today's trading range between $13.05 and $14.88. Over the past year, SI reached a high of $17.94 and a low of $13.05. The company's market capitalization is approximately $283.9 million, with a trading volume of 454,007 shares.

In comparison, Shoulder Innovations' IPO was priced below expectations due to a slowdown in revenue growth. Despite a modest valuation of three to four times its sales and a strong net cash position, the company faces challenges such as ongoing operating losses and competition from established medical technology giants like J&J and Stryker.

While Silvergate Capital's IPO pricing appears stable, the stock's recent performance indicates investor caution. The decrease in stock price and its fluctuation suggest that investors are closely monitoring the company's financial health and market conditions. As Silvergate Capital navigates its public offering, it will need to address these concerns to maintain investor confidence.

Published on: August 1, 2025